Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicProgress toward a Staphylococcus aureus vaccineDaptomycin in paediatrics: current knowledge and the need for future researchNeutrophils in innate host defense against Staphylococcus aureus infectionsInfective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infectionParapneumonic empyema deaths during past century, Utah.Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureusEpidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 eraEpidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates.Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumoniaWaves of resistance: Staphylococcus aureus in the antibiotic era.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Severe leukopenia in Staphylococcus aureus-necrotizing, community-acquired pneumonia: risk factors and impact on survival.Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee.Panton-Valentine leukocidin in community and hospital-acquired Staphylococcus aureus strains.Predictors of mortality in Staphylococcus aureus BacteremiaA model for surveillance of methicillin-resistant Staphylococcus aureus.Discriminatory Indices of Typing Methods for Epidemiologic Analysis of Contemporary Staphylococcus aureus Strains.Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children.Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.Community-associated meticillin-resistant Staphylococcus aureusCavitary pulmonary disease.Practices and procedures to prevent the transmission of skin and soft tissue infections in high school athletesCytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.Infectious Complications and Morbidities After Neonatal Bloodstream Infections: An Observational Cohort StudyCommunity-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management.Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits.The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300Pneumonia caused by methicillin-resistant Staphylococcus aureus.Para-aortic arch abscess secondary to Staphylococcus aureus pneumonia.
P2860
Q24614464-A4B6202E-2605-489A-A885-F9196AB450B4Q26829702-8F04B280-B1AC-49F8-BF71-43F2F3980037Q27006038-EB1D7520-4129-4035-8A9D-0A4CCEADC657Q27024628-7175967C-860C-4873-951C-398F11B7DBFAQ28264364-45A94C06-EA66-42E8-85B3-00466AC3D7A5Q30374152-F5BE393A-465E-41D2-B44C-142E93A4B7EAQ30384680-4D8DBDAA-B30E-4BF9-A2C2-47146EA18F9AQ30397675-CFD331DE-8703-418A-89CE-21B37F95073DQ33264579-6FC9071E-A3E7-4C5B-877E-27EE9AEAA0BEQ33305151-ED779262-48BA-4A8F-A90B-DED4C6F6B2D1Q33481265-82977BA9-DFB2-47EC-A7BE-E3279AE4591CQ33483064-62979FEE-B7C3-4ED5-AEE4-4A2FB3A7A8D6Q33604961-788FEF8D-5721-435D-B583-9B9C37CC0BBAQ33703737-A42A6AB5-FC6D-4E95-BCE0-43A9D994C679Q33822603-7F92695E-6038-4F57-AC31-4C2EC59ADEBBQ33854398-8CA688F8-374E-47E5-8257-995D591311F0Q34157657-31377DAB-C239-4E6A-BFBB-6A8015EC28B3Q34245797-88A5874D-FFF6-47EA-9858-1A62360EAAF6Q34478074-548174E8-EDF3-424E-9CA5-4A7C58C17D14Q34895007-3F9C55A5-5CF4-4A88-974C-90A89FBA2357Q34988113-274DB91B-E735-48E9-AFFF-D4CD6B78B751Q35117981-45C24A40-3288-4C72-BB9A-E76EEB6DCB10Q35221057-284124F1-E985-4904-B4C5-0F28C5BF2174Q35613368-3988504B-7D95-4F1D-B960-9C4B9B95082CQ35940556-A79BE698-A19C-4BBE-A49D-3F0D8998DAABQ36176953-04DA0493-7E07-41E2-A068-3FF590FADAA0Q36256138-C0C94CAD-EC53-47A0-9D62-D1C4592B1272Q36327319-89D0DABC-B2D0-4627-9F71-7D14FCCA697EQ36379346-AC3303EA-F4D9-429E-8599-88B3B8AD4A7BQ36438720-9FC42B9D-0FE4-47AA-9DE4-B1D1AFDCEDB2Q36538804-4C8CC33E-28B1-4C22-8E2D-017390921F97Q36679861-8E33FAA5-5C89-4E23-819B-115B67FB6D86Q36812827-2FEFCC05-45F2-43A2-B703-65EAE12439E2Q36822795-A78FC47B-6D37-47E0-97D3-039200B939D2Q36869311-6481350F-6ACB-4CF4-9482-DAFA6F929A27Q36882495-CCB106DC-DA6A-4A8A-8355-DAA6B0C0C56BQ36982947-E0714DCC-D616-4ED5-9B90-90AF1BF37DEDQ37132230-EDC57FA5-7671-49FA-824B-B8A7830A6037Q37156705-A775BF6C-1068-4012-B953-BA08F4B71FCDQ37252875-A13987A9-D5D0-4E00-AC90-2A3A1EC14EBC
P2860
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@en
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@nl
type
label
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@en
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@nl
prefLabel
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@en
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@nl
P2093
P2860
P356
P1476
Pulmonary manifestations in ch ...... aphylococcus aureus infection.
@en
P2093
Blanca E Gonzalez
Edward O Mason
Linda B Lamberth
Megan K Dishop
Sheldon L Kaplan
Wendy A Hammerman
P2860
P304
P356
10.1086/432475
P407
P577
2005-07-29T00:00:00Z